BRIDGEWATER, N.J., April 20,
2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq:
INSM), a global biopharmaceutical company on a mission to transform
the lives of patients with serious and rare diseases, today
announced that it will release its first quarter 2023 financial
results on Thursday, May 4, 2023.
Insmed management will host a conference call for investors
beginning at 8:30 a.m. ET on
Thursday, May 4, 2023, to discuss the financial results and
provide a business update.
Shareholders and other interested parties may participate in the
conference call by dialing (833) 470-1428 (U.S.) or (929) 526-1599
(international) and referencing access code 468531. The call will
also be webcast live on the company's website
at www.insmed.com.
A replay of the conference call will be accessible approximately
30 minutes after its completion through June
3, 2023, by dialing (866) 813-9403 (U.S.) or (+44)
204-525-0658 (international) and referencing access code 281829. A
webcast of the call will also be archived for 90 days under the
Investor Relations section of the company's website at
www.insmed.com.
About Insmed
Insmed Incorporated is a global biopharmaceutical company on a
mission to transform the lives of patients with serious and rare
diseases. Insmed's first commercial product is a first-in-disease
therapy approved in the United
States, Europe, and
Japan to treat a chronic,
debilitating lung disease. The Company is also progressing a robust
pipeline of investigational therapies targeting areas of serious
unmet need, including neutrophil-mediated inflammatory diseases and
rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a footprint
across Europe and in Japan. For more information, visit
www.insmed.com.
Contact:
Investors:
Bryan Dunn
Executive Director, Investor Relations
Insmed
(646) 812-4030
bryan.dunn@insmed.com
Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com
Media:
Mandy Fahey
Executive Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/insmed-to-host-first-quarter-2023-financial-results-conference-call-on-thursday-may-4-2023-301802291.html
SOURCE Insmed Incorporated